VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q41271935  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241020233019.0
008     241020nneanz||abbn n and d
035 ‎‡a  (WKP)Q41271935‏
024 ‎‡a  0000-0003-0443-9232‏ ‎‡2  orcid‏
024 ‎‡a  35516513600‏ ‎‡2  scopus‏
024 ‎‡a  7402798662‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q41271935‏
046 ‎‡f  19600000‏
100 0 ‎‡a  Torres JM‏ ‎‡9  ast‏ ‎‡9  es‏ ‎‡9  sl‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Juan Maria Torres‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Juan Maria Torres‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice‏
670 ‎‡a  Author's Alpha-fetoprotein gene expression in human lymphoblastoid cells and in PHA-stimulated normal T-lymphocytes‏
670 ‎‡a  Author's Alpha-fetoprotein-mediated uptake of fatty acids by human T lymphocytes‏
670 ‎‡a  Author's Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease‏
670 ‎‡a  Author's An assessment of the long-term persistence of prion infectivity in aquatic environments‏
670 ‎‡a  Author's Aquaporin 1 and aquaporin 4 overexpression in bovine spongiform encephalopathy in a transgenic murine model and in cattle field cases‏
670 ‎‡a  Author's Assessing the presence of BSE and scrapie in slaughterhouse wastewater‏
670 ‎‡a  Author's Both murine host and inoculum modulate expression of experimental variant Creutzfeldt-Jakob disease‏
670 ‎‡a  Author's Bovine spongiform encephalopathy agent in spleen from an ARR/ARR orally exposed sheep‏
670 ‎‡a  Author's Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features.‏
670 ‎‡a  Author's Carrier-protein-mediated enhancement of fatty-acid binding and internalization in human T-lymphocytes‏
670 ‎‡a  Author's Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice‏
670 ‎‡a  Author's Central nervous system extracellular matrix changes in a transgenic mouse model of bovine spongiform encephalopathy‏
670 ‎‡a  Author's Central nervous system gene expression changes in a transgenic mouse model for bovine spongiform encephalopathy‏
670 ‎‡a  Author's Changes in lipid composition of human peripheral blood lymphocytes infected by HIV‏
670 ‎‡a  Author's Characterization of goat prions demonstrates geographical variation of scrapie strains in Europe and reveals the composite nature of prion strains‏
670 ‎‡a  Author's Classical bovine spongiform encephalopathy by transmission of H-type prion in homologous prion protein context.‏
670 ‎‡a  Author's Coenzyme Q and protein/lipid oxidation in a BSE-infected transgenic mouse model.‏
670 ‎‡a  Author's Comparison of mRNA expression levels of selected genes in the brain stem of cattle naturally infected with classical and atypical BSE.‏
670 ‎‡a  Author's Comparison of three monoclonal antibodies for use in immunohistochemical detection of bovine spongiform encephalopathy protease-resistant prion protein‏
670 ‎‡a  Author's Cytotoxicity of chlorambucil and chlorambucil-fatty acid conjugates against human lymphomas and normal human peripheral blood lymphocytes‏
670 ‎‡a  Author's Defective uptake of alpha-fetoprotein‏
670 ‎‡a  Author's Defective uptake of alpha-fetoprotein (AFP) and transferrin (Tf) by PHA-activated peripheral blood lymphocytes from patients with AIDS and related syndromes‏
670 ‎‡a  Author's Detection and survival of prion agents in aquatic environments.‏
670 ‎‡a  Author's Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease‏
670 ‎‡a  Author's Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation.‏
670 ‎‡a  Author's Discrimination of sheep susceptible and resistant to transmissible spongiform encephalopathies by an haplotype specific monoclonal antibody‏
670 ‎‡a  Author's Distribution of the cellular prion protein‏
670 ‎‡a  Author's Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species‏
670 ‎‡a  Author's DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge‏
670 ‎‡a  Author's Dysfunction of the PI3K-Akt-GSK-3 pathway is a common feature in cell culture and in vivo models of prion disease.‏
670 ‎‡a  Author's Early detection of PrPres in BSE-infected bovine PrP transgenic mice‏
670 ‎‡a  Author's Effect of Q211 and K222 PRNP Polymorphic Variants in the Susceptibility of Goats to Oral Infection With Goat Bovine Spongiform Encephalopathy‏
670 ‎‡a  Author's Elements modulating the prion species barrier and its passage consequences‏
670 ‎‡a  Author's Emergence of classical BSE strain properties during serial passages of H-BSE in wild-type mice.‏
670 ‎‡a  Author's Endocytosis of three serum proteins of a multigene family and of arachidonic acid in human lectin-stimulated T lymphocytes.‏
670 ‎‡a  Author's Epidemiological indication for a role of sheep in the emergence of variant Creutzfeldt-Jakob disease‏
670 ‎‡a  Author's Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases‏
670 ‎‡a  Author's Evaluation of the zoonotic potential of transmissible mink encephalopathy‏
670 ‎‡a  Author's Evidence for zoonotic potential of ovine scrapie prions.‏
670 ‎‡a  Author's Excretion of BSE and scrapie prions in stools from murine models‏
670 ‎‡a  Author's Exploring the risks of a putative transmission of BSE to new species‏
670 ‎‡a  Author's Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation‏
670 ‎‡a  Author's Fatty acid metabolism in human lymphocytes. I. Time-course changes in fatty acid composition and membrane fluidity during blastic transformation of peripheral blood lymphocytes‏
670 ‎‡a  Author's First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease‏
670 ‎‡a  Author's Foodborne transmission of bovine spongiform encephalopathy to nonhuman primates‏
670 ‎‡a  Author's Further characterisation of transmissible spongiform encephalopathy phenotypes after inoculation of cattle with two temporally separated sources of sheep scrapie from Great Britain‏
670 ‎‡a  Author's Genetic resistance to scrapie infection in experimentally challenged goats‏
670 ‎‡a  Author's Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.‏
670 ‎‡a  Author's Glutathione status and sensitivity to GSH-reacting compounds of Escherichia coli strains deficient in glutathione metabolism and/or catalase activity.‏
670 ‎‡a  Author's Goat K222-PrP(C) polymorphic variant does not provide resistance to atypical scrapie in transgenic mice‏
670 ‎‡a  Author's Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice‏
670 ‎‡a  Author's Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.‏
670 ‎‡a  Author's Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis‏
670 ‎‡a  Author's Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice‏
670 ‎‡a  Author's Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein‏
670 ‎‡a  Author's Infectivity in bone marrow from sporadic CJD patients.‏
670 ‎‡a  Author's Involvement of PrP(C) in kainate-induced excitotoxicity in several mouse strains‏
670 ‎‡a  Author's Involvement of the immunological system in the pathogenesis of transmissible spongiform encephalopathies‏
670 ‎‡a  Author's Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates.‏
670 ‎‡a  Author's Late stage cathepsin C, CXCL13 and Ki-67 overexpression correlate with regional neuropathology in a BSE transgenic murine model.‏
670 ‎‡a  Author's Mapping of neurotrophins and their receptors in the adult mouse brain and their role in the pathogenesis of a transgenic murine model of bovine spongiform encephalopathy.‏
670 ‎‡a  Author's Membrane proteins from lymphoblastoid cells showing cross-affinity for alpha-fetoprotein and albumin. Isolation and characterization‏
670 ‎‡a  Author's Met<sub>166</sub> -Glu<sub>168</sub> residues in human PrP β2-α2 loop account for evolutionary resistance to prion infection‏
670 ‎‡a  Author's Met<sub>166</sub> -Glu<sub>168</sub> residues in human PrP β2-α2 loop account for evolutionary resistance to prion infection‏
670 ‎‡a  Author's MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease‏
670 ‎‡a  Author's Non-pathogenic heterologous prions can interfere with prion infection in a strain dependent manner‏
670 ‎‡a  Author's Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance‏
670 ‎‡a  Author's Persistence of the bovine spongiform encephalopathy infectious agent in sewage‏
670 ‎‡a  Author's Pre-symptomatic detection of prions by cyclic amplification of protein misfolding.‏
670 ‎‡a  Author's Presumptive BSE cases with an aberrant prion protein phenotype in Switzerland, 2011: Lack of prion disease in experimentally inoculated cattle and bovine prion protein transgenic mice‏
670 ‎‡a  Author's Prion and prion-like diseases in animals.‏
670 ‎‡a  Author's Prion infection of differentiated neurospheres‏
670 ‎‡a  Author's Progression of prion infectivity in asymptomatic cattle after oral bovine spongiform encephalopathy challenge‏
670 ‎‡a  Author's Protective Effect of Val129-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease.‏
670 ‎‡a  Author's Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11.‏
670 ‎‡a  Author's PrP(106-126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independently of PrPc‏
670 ‎‡a  Author's PrP(C) regulates epidermal growth factor receptor function and cell shape dynamics in Neuro2a cells.‏
670 ‎‡a  Author's PrPC Governs Susceptibility to Prion Strains in Bank Vole, While Other Host Factors Modulate Strain Features.‏
670 ‎‡a  Author's Quantification of alpha-fetoprotein and transferrin endocytosis by lymphoid cells using flow cytometry‏
670 ‎‡a  Author's Receptor-mediated endocytosis and recycling of alpha-fetoprotein in human B-lymphoma and T-leukemia cells‏
670 ‎‡a  Author's Reduced susceptibility to bovine spongiform encephalopathy prions in transgenic mice expressing a bovine PrP with five octapeptide repeats.‏
670 ‎‡a  Author's Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies.‏
670 ‎‡a  Author's Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.‏
670 ‎‡a  Author's Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice‏
670 ‎‡a  Author's RNA editing alterations define manifestation of prion diseases‏
670 ‎‡a  Author's Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS.‏
670 ‎‡a  Author's Role of the goat K222-PrP‏
670 ‎‡a  Author's Role of the goat K222-PrP(C) polymorphic variant in prion infection resistance‏
670 ‎‡a  Author's Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease.‏
670 ‎‡a  Author's Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.‏
670 ‎‡a  Author's Spontaneous generation of infectious prion disease in transgenic mice‏
670 ‎‡a  Author's Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner‏
670 ‎‡a  Author's Stress response in the central nervous system of a transgenic mouse model of bovine spongiform encephalopathy‏
670 ‎‡a  Author's Structural and functional analysis of the ovine laminin receptor gene‏
670 ‎‡a  Author's Structural and functional analysis of the ovine laminin receptor gene (RPSA): Possible involvement of the LRP/LR protein in scrapie response.‏
670 ‎‡a  Author's Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein.‏
670 ‎‡a  Author's Synthesis in vitro of rabbit hemorrhagic disease virus subgenomic RNA by internal initiation on (-)sense genomic RNA: mapping of a subgenomic promoter.‏
670 ‎‡a  Author's The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells.‏
670 ‎‡a  Author's The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid.‏
670 ‎‡a  Author's The emergence of classical BSE from atypical/Nor98 scrapie‏
670 ‎‡a  Author's The Priority position paper: Protecting Europe's food chain from prions‏
670 ‎‡a  Author's The proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animals‏
670 ‎‡a  Author's Thermostability as a highly dependent prion strain feature‏
670 ‎‡a  Author's Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection.‏
670 ‎‡a  Author's Transgenic mouse models expressing human and macaque prion protein exhibit similar prion susceptibility on a strain-dependent manner‏
670 ‎‡a  Author's Transmission and Replication of Prions.‏
670 ‎‡a  Author's Transmission characteristics of variably protease-sensitive prionopathy.‏
670 ‎‡a  Author's Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.‏
670 ‎‡a  Author's Vertical transmission of bovine spongiform encephalopathy prions evaluated in a transgenic mouse model.‏
670 ‎‡a  Author's YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/viaf/229399252‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/SUDOC|174220839‏
909 ‎‡a  (orcid) 0000000304439232‏ ‎‡9  1‏
909 ‎‡a  (scopus) 35516513600‏ ‎‡9  1‏
909 ‎‡a  (scopus) 7402798662‏ ‎‡9  1‏
919 ‎‡a  quantificationofalphafetoproteinandtransferrinendocytosisbylymphoidcellsusingflowcytometry‏ ‎‡A  Quantification of alpha-fetoprotein and transferrin endocytosis by lymphoid cells using flow cytometry‏ ‎‡9  1‏
919 ‎‡a  adenosinea1receptorproteinlevelsandactivityisincreasedinthecerebralcortexincreutzfeldtjakobdiseaseandinbovinespongiformencephalopathyinfectedbovineprpmice‏ ‎‡A  Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice‏ ‎‡9  1‏
919 ‎‡a  alphafetoproteingeneexpressioninhumanlymphoblastoidcellsandinphastimulatednormaltlymphocytes‏ ‎‡A  Alpha-fetoprotein gene expression in human lymphoblastoid cells and in PHA-stimulated normal T-lymphocytes‏ ‎‡9  1‏
919 ‎‡a  alphafetoproteinmediateduptakeoffattyacidsbyhumantlymphocytes‏ ‎‡A  Alpha-fetoprotein-mediated uptake of fatty acids by human T lymphocytes‏ ‎‡9  1‏
919 ‎‡a  alteredca2+homeostasisinducescalpaincathepsinaxisactivationinsporadiccreutzfeldtjakobdisease‏ ‎‡A  Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease‏ ‎‡9  1‏
919 ‎‡a  assessmentofthelongtermpersistenceofprioninfectivityinaquaticenvironments‏ ‎‡A  An assessment of the long-term persistence of prion infectivity in aquatic environments‏ ‎‡9  1‏
919 ‎‡a  aquaporin1andaquaporin4overexpressioninbovinespongiformencephalopathyinatransgenicmurinemodelandincattlefieldcases‏ ‎‡A  Aquaporin 1 and aquaporin 4 overexpression in bovine spongiform encephalopathy in a transgenic murine model and in cattle field cases‏ ‎‡9  1‏
919 ‎‡a  assessingthepresenceofbseandscrapieinslaughterhousewastewater‏ ‎‡A  Assessing the presence of BSE and scrapie in slaughterhouse wastewater‏ ‎‡9  1‏
919 ‎‡a  bothmurinehostandinoculummodulateexpressionofexperimentalvariantcreutzfeldtjakobdisease‏ ‎‡A  Both murine host and inoculum modulate expression of experimental variant Creutzfeldt-Jakob disease‏ ‎‡9  1‏
919 ‎‡a  bovinespongiformencephalopathyagentinspleenfromanarrarrorallyexposedsheep‏ ‎‡A  Bovine spongiform encephalopathy agent in spleen from an ARR/ARR orally exposed sheep‏ ‎‡9  1‏
919 ‎‡a  bovinespongiformencephalopathyinducesmisfoldingofallegedprionresistantspeciescellularprionproteinwithoutalteringitspathobiologicalfeatures‏ ‎‡A  Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features.‏ ‎‡9  1‏
919 ‎‡a  carrierproteinmediatedenhancementoffattyacidbindingandinternalizationinhumantlymphocytes‏ ‎‡A  Carrier-protein-mediated enhancement of fatty-acid binding and internalization in human T-lymphocytes‏ ‎‡9  1‏
919 ‎‡a  cellularprionproteinmodulatesβamyloiddepositioninagedappps1transgenicmice‏ ‎‡A  Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice‏ ‎‡9  1‏
919 ‎‡a  centralnervoussystemextracellularmatrixchangesinatransgenicmousemodelofbovinespongiformencephalopathy‏ ‎‡A  Central nervous system extracellular matrix changes in a transgenic mouse model of bovine spongiform encephalopathy‏ ‎‡9  1‏
919 ‎‡a  centralnervoussystemgeneexpressionchangesinatransgenicmousemodelforbovinespongiformencephalopathy‏ ‎‡A  Central nervous system gene expression changes in a transgenic mouse model for bovine spongiform encephalopathy‏ ‎‡9  1‏
919 ‎‡a  changesinlipidcompositionofhumanperipheralbloodlymphocytesinfectedbyhiv‏ ‎‡A  Changes in lipid composition of human peripheral blood lymphocytes infected by HIV‏ ‎‡9  1‏
919 ‎‡a  characterizationofgoatprionsdemonstratesgeographicalvariationofscrapiestrainsineuropeandrevealsthecompositenatureofprionstrains‏ ‎‡A  Characterization of goat prions demonstrates geographical variation of scrapie strains in Europe and reveals the composite nature of prion strains‏ ‎‡9  1‏
919 ‎‡a  classicalbovinespongiformencephalopathybytransmissionofhtypeprioninhomologousprionproteincontext‏ ‎‡A  Classical bovine spongiform encephalopathy by transmission of H-type prion in homologous prion protein context.‏ ‎‡9  1‏
919 ‎‡a  coenzymeqandproteinlipidoxidationinabseinfectedtransgenicmousemodel‏ ‎‡A  Coenzyme Q and protein/lipid oxidation in a BSE-infected transgenic mouse model.‏ ‎‡9  1‏
919 ‎‡a  comparisonofmrnaexpressionlevelsofselectedgenesinthebrainstemofcattlenaturallyinfectedwithclassicalandatypicalbse‏ ‎‡A  Comparison of mRNA expression levels of selected genes in the brain stem of cattle naturally infected with classical and atypical BSE.‏ ‎‡9  1‏
919 ‎‡a  comparisonof3monoclonalantibodiesforuseinimmunohistochemicaldetectionofbovinespongiformencephalopathyproteaseresistantprionprotein‏ ‎‡A  Comparison of three monoclonal antibodies for use in immunohistochemical detection of bovine spongiform encephalopathy protease-resistant prion protein‏ ‎‡9  1‏
919 ‎‡a  cytotoxicityofchlorambucilandchlorambucilfattyacidconjugatesagainsthumanlymphomasandnormalhumanperipheralbloodlymphocytes‏ ‎‡A  Cytotoxicity of chlorambucil and chlorambucil-fatty acid conjugates against human lymphomas and normal human peripheral blood lymphocytes‏ ‎‡9  1‏
919 ‎‡a  defectiveuptakeofalphafetoprotein‏ ‎‡A  Defective uptake of alpha-fetoprotein‏ ‎‡9  1‏
919 ‎‡a  defectiveuptakeofalphafetoproteinafpandtransferrintfbyphaactivatedperipheralbloodlymphocytesfrompatientswithaidsandrelatedsyndromes‏ ‎‡A  Defective uptake of alpha-fetoprotein (AFP) and transferrin (Tf) by PHA-activated peripheral blood lymphocytes from patients with AIDS and related syndromes‏ ‎‡9  1‏
919 ‎‡a  detectionandsurvivalofprionagentsinaquaticenvironments‏ ‎‡A  Detection and survival of prion agents in aquatic environments.‏ ‎‡9  1‏
919 ‎‡a  detectionofinfectivityinbloodofpersonswithvariantandsporadiccreutzfeldtjakobdisease‏ ‎‡A  Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease‏ ‎‡9  1‏
919 ‎‡a  differentbehaviortowardbovinespongiformencephalopathyinfectionofbovineprionproteintransgenicmicewith1extrarepeatoctapeptideinsertmutation‏ ‎‡A  Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation.‏ ‎‡9  1‏
919 ‎‡a  discriminationofsheepsusceptibleandresistanttotransmissiblespongiformencephalopathiesbyanhaplotypespecificmonoclonalantibody‏ ‎‡A  Discrimination of sheep susceptible and resistant to transmissible spongiform encephalopathies by an haplotype specific monoclonal antibody‏ ‎‡9  1‏
919 ‎‡a  distributionofthecellularprionprotein‏ ‎‡A  Distribution of the cellular prion protein‏ ‎‡9  1‏
919 ‎‡a  distributionofthecellularprionproteinprpcinbrainsoflivestockanddomesticatedspecies‏ ‎‡A  Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species‏ ‎‡9  1‏
919 ‎‡a  dnavaccinationcanbreakimmunologicaltolerancetoprpinwildtypemiceandattenuatespriondiseaseafterintracerebralchallenge‏ ‎‡A  DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge‏ ‎‡9  1‏
919 ‎‡a  dysfunctionofthepi3kaktgsk3pathwayisacommonfeatureincellcultureandinvivomodelsofpriondisease‏ ‎‡A  Dysfunction of the PI3K-Akt-GSK-3 pathway is a common feature in cell culture and in vivo models of prion disease.‏ ‎‡9  1‏
919 ‎‡a  earlydetectionofprpresinbseinfectedbovineprptransgenicmice‏ ‎‡A  Early detection of PrPres in BSE-infected bovine PrP transgenic mice‏ ‎‡9  1‏
919 ‎‡a  effectofq211andk222prnppolymorphicvariantsinthesusceptibilityofgoatstooralinfectionwithgoatbovinespongiformencephalopathy‏ ‎‡A  Effect of Q211 and K222 PRNP Polymorphic Variants in the Susceptibility of Goats to Oral Infection With Goat Bovine Spongiform Encephalopathy‏ ‎‡9  1‏
919 ‎‡a  elementsmodulatingtheprionspeciesbarrieranditspassageconsequences‏ ‎‡A  Elements modulating the prion species barrier and its passage consequences‏ ‎‡9  1‏
919 ‎‡a  emergenceofclassicalbsestrainpropertiesduringserialpassagesofhbseinwildtypemice‏ ‎‡A  Emergence of classical BSE strain properties during serial passages of H-BSE in wild-type mice.‏ ‎‡9  1‏
919 ‎‡a  endocytosisof3serumproteinsofamultigenefamilyandofarachidonicacidinhumanlectinstimulatedtlymphocytes‏ ‎‡A  Endocytosis of three serum proteins of a multigene family and of arachidonic acid in human lectin-stimulated T lymphocytes.‏ ‎‡9  1‏
919 ‎‡a  epidemiologicalindicationforaroleofsheepintheemergenceofvariantcreutzfeldtjakobdisease‏ ‎‡A  Epidemiological indication for a role of sheep in the emergence of variant Creutzfeldt-Jakob disease‏ ‎‡9  1‏
919 ‎‡a  epigeneticcontrolofthenotchandephsignalingpathwaysbytheprionproteinimplicationsforpriondiseases‏ ‎‡A  Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases‏ ‎‡9  1‏
919 ‎‡a  evaluationofthezoonoticpotentialoftransmissibleminkencephalopathy‏ ‎‡A  Evaluation of the zoonotic potential of transmissible mink encephalopathy‏ ‎‡9  1‏
919 ‎‡a  evidenceforzoonoticpotentialofovinescrapieprions‏ ‎‡A  Evidence for zoonotic potential of ovine scrapie prions.‏ ‎‡9  1‏
919 ‎‡a  excretionofbseandscrapieprionsinstoolsfrommurinemodels‏ ‎‡A  Excretion of BSE and scrapie prions in stools from murine models‏ ‎‡9  1‏
919 ‎‡a  exploringtherisksofaputativetransmissionofbsetonewspecies‏ ‎‡A  Exploring the risks of a putative transmission of BSE to new species‏ ‎‡9  1‏
919 ‎‡a  expressionofalphafetoproteinreceptorsbyhumantlymphocytesduringblastictransformation‏ ‎‡A  Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation‏ ‎‡9  1‏
919 ‎‡a  fattyacidmetabolisminhumanlymphocytes1timecoursechangesinfattyacidcompositionandmembranefluidityduringblastictransformationofperipheralbloodlymphocytes‏ ‎‡A  Fatty acid metabolism in human lymphocytes. I. Time-course changes in fatty acid composition and membrane fluidity during blastic transformation of peripheral blood lymphocytes‏ ‎‡9  1‏
919 ‎‡a  1fieldtrialofatransmissiblerecombinantvaccineagainstmyxomatosisandrabbithemorrhagicdisease‏ ‎‡A  First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease‏ ‎‡9  1‏
919 ‎‡a  foodbornetransmissionofbovinespongiformencephalopathytononhumanprimates‏ ‎‡A  Foodborne transmission of bovine spongiform encephalopathy to nonhuman primates‏ ‎‡9  1‏
919 ‎‡a  furthercharacterisationoftransmissiblespongiformencephalopathyphenotypesafterinoculationofcattlewith2temporallyseparatedsourcesofsheepscrapiefromgreatbritain‏ ‎‡A  Further characterisation of transmissible spongiform encephalopathy phenotypes after inoculation of cattle with two temporally separated sources of sheep scrapie from Great Britain‏ ‎‡9  1‏
919 ‎‡a  geneticresistancetoscrapieinfectioninexperimentallychallengedgoats‏ ‎‡A  Genetic resistance to scrapie infection in experimentally challenged goats‏ ‎‡9  1‏
919 ‎‡a  genomecomparisonofanonpathogenicmyxomavirusfieldstrainwithitsancestorthevirulentlausannestrain‏ ‎‡A  Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.‏ ‎‡9  1‏
919 ‎‡a  glutathionestatusandsensitivitytogshreactingcompoundsofescherichiacolistrainsdeficientinglutathionemetabolismandorcatalaseactivity‏ ‎‡A  Glutathione status and sensitivity to GSH-reacting compounds of Escherichia coli strains deficient in glutathione metabolism and/or catalase activity.‏ ‎‡9  1‏
919 ‎‡a  goatk222prp100polymorphicvariantdoesnotprovideresistancetoatypicalscrapieintransgenicmice‏ ‎‡A  Goat K222-PrP(C) polymorphic variant does not provide resistance to atypical scrapie in transgenic mice‏ ‎‡9  1‏
919 ‎‡a  group1mglursignalinginbseinfectedbovineprptransgenicmice‏ ‎‡A  Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice‏ ‎‡9  1‏
919 ‎‡a  horizontaltransmissibleprotectionagainstmyxomatosisandrabbithemorrhagicdiseasebyusingarecombinantmyxomavirus‏ ‎‡A  Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.‏ ‎‡9  1‏
919 ‎‡a  immunotherapeuticeffectofantiprpmonoclonalantibodiesintransmissiblespongiformencephalopathymousemodelspharmacokineticandpharmacodynamicanalysis‏ ‎‡A  Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis‏ ‎‡9  1‏
919 ‎‡a  increasedexpressionofwaterchannelaquaporin1andaquaporin4increutzfeldtjakobdiseaseandinbovinespongiformencephalopathyinfectedbovineprptransgenicmice‏ ‎‡A  Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice‏ ‎‡9  1‏
919 ‎‡a  inductionofantibodiesprotectingagainsttransmissiblegastroenteritiscoronavirustgevbyrecombinantadenovirusexpressingtgevspikeprotein‏ ‎‡A  Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein‏ ‎‡9  1‏
919 ‎‡a  infectivityinbonemarrowfromsporadiccjdpatients‏ ‎‡A  Infectivity in bone marrow from sporadic CJD patients.‏ ‎‡9  1‏
919 ‎‡a  involvementofprp100inkainateinducedexcitotoxicityinseveralmousestrains‏ ‎‡A  Involvement of PrP(C) in kainate-induced excitotoxicity in several mouse strains‏ ‎‡9  1‏
919 ‎‡a  involvementoftheimmunologicalsysteminthepathogenesisoftransmissiblespongiformencephalopathies‏ ‎‡A  Involvement of the immunological system in the pathogenesis of transmissible spongiform encephalopathies‏ ‎‡9  1‏
919 ‎‡a  isolationofanattenuatedmyxomavirusfieldstrainthatcanconferprotectionagainstmyxomatosisoncontactsofvaccinates‏ ‎‡A  Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates.‏ ‎‡9  1‏
919 ‎‡a  latestagecathepsin100cxcl13andki67overexpressioncorrelatewithregionalneuropathologyinabsetransgenicmurinemodel‏ ‎‡A  Late stage cathepsin C, CXCL13 and Ki-67 overexpression correlate with regional neuropathology in a BSE transgenic murine model.‏ ‎‡9  1‏
919 ‎‡a  mappingofneurotrophinsandtheirreceptorsintheadultmousebrainandtheirroleinthepathogenesisofatransgenicmurinemodelofbovinespongiformencephalopathy‏ ‎‡A  Mapping of neurotrophins and their receptors in the adult mouse brain and their role in the pathogenesis of a transgenic murine model of bovine spongiform encephalopathy.‏ ‎‡9  1‏
919 ‎‡a  membraneproteinsfromlymphoblastoidcellsshowingcrossaffinityforalphafetoproteinandalbuminisolationandcharacterization‏ ‎‡A  Membrane proteins from lymphoblastoid cells showing cross-affinity for alpha-fetoprotein and albumin. Isolation and characterization‏ ‎‡9  1‏
919 ‎‡a  metsub166subglusub168subresiduesinhumanprpi2212loopaccountforevolutionaryresistancetoprioninfection‏ ‎‡A  Met<sub>166</sub> -Glu<sub>168</sub> residues in human PrP β2-α2 loop account for evolutionary resistance to prion infection‏ ‎‡9  1‏
919 ‎‡a  metsub166subglusub168subresiduesinhumanprpβ2α2loopaccountforevolutionaryresistancetoprioninfection‏ ‎‡A  Met<sub>166</sub> -Glu<sub>168</sub> residues in human PrP β2-α2 loop account for evolutionary resistance to prion infection‏ ‎‡9  1‏
919 ‎‡a  micrornaalterationsinatg501mousemodelofpriondisease‏ ‎‡A  MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease‏ ‎‡9  1‏
919 ‎‡a  nonpathogenicheterologousprionscaninterferewithprioninfectioninastraindependentmanner‏ ‎‡A  Non-pathogenic heterologous prions can interfere with prion infection in a strain dependent manner‏ ‎‡9  1‏
919 ‎‡a  pathogenicprionsdeviateprp100signalinginneuronalcellsandimpairabetaclearance‏ ‎‡A  Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance‏ ‎‡9  1‏
919 ‎‡a  persistenceofthebovinespongiformencephalopathyinfectiousagentinsewage‏ ‎‡A  Persistence of the bovine spongiform encephalopathy infectious agent in sewage‏ ‎‡9  1‏
919 ‎‡a  presymptomaticdetectionofprionsbycyclicamplificationofproteinmisfolding‏ ‎‡A  Pre-symptomatic detection of prions by cyclic amplification of protein misfolding.‏ ‎‡9  1‏
919 ‎‡a  presumptivebsecaseswithanaberrantprionproteinphenotypeinswitzerland2011lackofpriondiseaseinexperimentallyinoculatedcattleandbovineprionproteintransgenicmice‏ ‎‡A  Presumptive BSE cases with an aberrant prion protein phenotype in Switzerland, 2011: Lack of prion disease in experimentally inoculated cattle and bovine prion protein transgenic mice‏ ‎‡9  1‏
919 ‎‡a  prionandprionlikediseasesinanimals‏ ‎‡A  Prion and prion-like diseases in animals.‏ ‎‡9  1‏
919 ‎‡a  prioninfectionofdifferentiatedneurospheres‏ ‎‡A  Prion infection of differentiated neurospheres‏ ‎‡9  1‏
919 ‎‡a  progressionofprioninfectivityinasymptomaticcattleafteroralbovinespongiformencephalopathychallenge‏ ‎‡A  Progression of prion infectivity in asymptomatic cattle after oral bovine spongiform encephalopathy challenge‏ ‎‡9  1‏
919 ‎‡a  protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease‏ ‎‡A  Protective Effect of Val129-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease.‏ ‎‡9  1‏
919 ‎‡a  proteinasekenhancedimmunoreactivityoftheprionproteinspecificmonoclonalantibody2a11‏ ‎‡A  Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11.‏ ‎‡9  1‏
919 ‎‡a  prp106126activatesneuronalintracellularkinasesandegr1synthesisthroughactivationofnadphoxidaseindependentlyofprpc‏ ‎‡A  PrP(106-126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independently of PrPc‏ ‎‡9  1‏
919 ‎‡a  prp100regulatesepidermalgrowthfactorreceptorfunctionandcellshapedynamicsinneuro2acells‏ ‎‡A  PrP(C) regulates epidermal growth factor receptor function and cell shape dynamics in Neuro2a cells.‏ ‎‡9  1‏
919 ‎‡a  prpcgovernssusceptibilitytoprionstrainsinbankvolewhileotherhostfactorsmodulatestrainfeatures‏ ‎‡A  PrPC Governs Susceptibility to Prion Strains in Bank Vole, While Other Host Factors Modulate Strain Features.‏ ‎‡9  1‏
919 ‎‡a  ykl40inthebrainandcerebrospinalfluidofneurodegenerativedementias‏ ‎‡A  YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.‏ ‎‡9  1‏
919 ‎‡a  verticaltransmissionofbovinespongiformencephalopathyprionsevaluatedinatransgenicmousemodel‏ ‎‡A  Vertical transmission of bovine spongiform encephalopathy prions evaluated in a transgenic mouse model.‏ ‎‡9  1‏
919 ‎‡a  variablyproteasesensitiveprionopathyanewsporadicdiseaseoftheprionprotein‏ ‎‡A  Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.‏ ‎‡9  1‏
919 ‎‡a  transmissioncharacteristicsofvariablyproteasesensitiveprionopathy‏ ‎‡A  Transmission characteristics of variably protease-sensitive prionopathy.‏ ‎‡9  1‏
919 ‎‡a  transmissionandreplicationofprions‏ ‎‡A  Transmission and Replication of Prions.‏ ‎‡9  1‏
919 ‎‡a  transgenicmousemodelsexpressinghumanandmacaqueprionproteinexhibitsimilarprionsusceptibilityonastraindependentmanner‏ ‎‡A  Transgenic mouse models expressing human and macaque prion protein exhibit similar prion susceptibility on a strain-dependent manner‏ ‎‡9  1‏
919 ‎‡a  transgenicmiceexpressingbovineprpwitha4extrarepeatoctapeptideinsertmutationshowaspontaneousnontransmissibleneurodegenerativediseaseandanexpeditedcourseofbseinfection‏ ‎‡A  Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection.‏ ‎‡9  1‏
919 ‎‡a  thermostabilityasahighlydependentprionstrainfeature‏ ‎‡A  Thermostability as a highly dependent prion strain feature‏ ‎‡9  1‏
919 ‎‡a  proximalpromoterregionofmtertissufficienttoregulatetelomeraseactivityinescellsandtransgenicanimals‏ ‎‡A  The proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animals‏ ‎‡9  1‏
919 ‎‡a  prioritypositionpaperprotectingeuropesfoodchainfromprions‏ ‎‡A  The Priority position paper: Protecting Europe's food chain from prions‏ ‎‡9  1‏
919 ‎‡a  emergenceofclassicalbsefromatypicalnor98scrapie‏ ‎‡A  The emergence of classical BSE from atypical/Nor98 scrapie‏ ‎‡9  1‏
919 ‎‡a  coatproteinofrabbithemorrhagicdiseaseviruscontainsamolecularswitchatthenterminalregionfacingtheinnersurfaceofthecapsid‏ ‎‡A  The coat protein of Rabbit hemorrhagic disease virus contains a molecular switch at the N-terminal region facing the inner surface of the capsid.‏ ‎‡9  1‏
919 ‎‡a  cellularprionproteincontrolsnotchsignalinginneuralstemprogenitorcells‏ ‎‡A  The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells.‏ ‎‡9  1‏
919 ‎‡a  synthesisinvitroofrabbithemorrhagicdiseasevirussubgenomicrnabyinternalinitiationonsensegenomicrnamappingofasubgenomicpromoter‏ ‎‡A  Synthesis in vitro of rabbit hemorrhagic disease virus subgenomic RNA by internal initiation on (-)sense genomic RNA: mapping of a subgenomic promoter.‏ ‎‡9  1‏
919 ‎‡a  subclinicalbovinespongiformencephalopathyinfectionintransgenicmiceexpressingporcineprionprotein‏ ‎‡A  Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein.‏ ‎‡9  1‏
919 ‎‡a  structuralandfunctionalanalysisoftheovinelamininreceptorgenerpsapossibleinvolvementofthelrplrproteininscrapieresponse‏ ‎‡A  Structural and functional analysis of the ovine laminin receptor gene (RPSA): Possible involvement of the LRP/LR protein in scrapie response.‏ ‎‡9  1‏
919 ‎‡a  structuralandfunctionalanalysisoftheovinelamininreceptorgene‏ ‎‡A  Structural and functional analysis of the ovine laminin receptor gene‏ ‎‡9  1‏
919 ‎‡a  stressresponseinthecentralnervoussystemofatransgenicmousemodelofbovinespongiformencephalopathy‏ ‎‡A  Stress response in the central nervous system of a transgenic mouse model of bovine spongiform encephalopathy‏ ‎‡9  1‏
919 ‎‡a  stemcelltherapyextendsincubationandsurvivaltimeinprioninfectedmiceinatimewindowdependantmanner‏ ‎‡A  Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner‏ ‎‡9  1‏
919 ‎‡a  spontaneousgenerationofinfectiouspriondiseaseintransgenicmice‏ ‎‡A  Spontaneous generation of infectious prion disease in transgenic mice‏ ‎‡9  1‏
919 ‎‡a  sheeppassagedbovinespongiformencephalopathyagentexhibitsalteredpathobiologicalpropertiesinbovineprptransgenicmice‏ ‎‡A  Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.‏ ‎‡9  1‏
919 ‎‡a  safetyevaluationofarecombinantmyxomarhdvvirusinducinghorizontaltransmissibleprotectionagainstmyxomatosisandrabbithaemorrhagicdisease‏ ‎‡A  Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease.‏ ‎‡9  1‏
919 ‎‡a  roleofthegoatk222prp100polymorphicvariantinprioninfectionresistance‏ ‎‡A  Role of the goat K222-PrP(C) polymorphic variant in prion infection resistance‏ ‎‡9  1‏
919 ‎‡a  roleofthegoatk222prp‏ ‎‡A  Role of the goat K222-PrP‏ ‎‡9  1‏
919 ‎‡a  roleofthecellularprionproteininoligodendrocyteprecursorcellproliferationanddifferentiationinthedevelopingandadultmousecns‏ ‎‡A  Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS.‏ ‎‡9  1‏
919 ‎‡a  rnaeditingalterationsdefinemanifestationofpriondiseases‏ ‎‡A  RNA editing alterations define manifestation of prion diseases‏ ‎‡9  1‏
919 ‎‡a  regulationofgabaaandglutamatereceptorexpressionsynapticfacilitationandlongtermpotentiationinthehippocampusofprionmutantmice‏ ‎‡A  Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice‏ ‎‡9  1‏
919 ‎‡a  regionalandsubtypedependentmirnasignaturesinsporadiccreutzfeldtjakobdiseaseareaccompaniedbyalterationsinmirnasilencingmachineryandbiogenesis‏ ‎‡A  Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.‏ ‎‡9  1‏
919 ‎‡a  reelinexpressionincreutzfeldtjakobdiseaseandexperimentalmodelsoftransmissiblespongiformencephalopathies‏ ‎‡A  Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies.‏ ‎‡9  1‏
919 ‎‡a  reducedsusceptibilitytobovinespongiformencephalopathyprionsintransgenicmiceexpressingabovineprpwith5octapeptiderepeats‏ ‎‡A  Reduced susceptibility to bovine spongiform encephalopathy prions in transgenic mice expressing a bovine PrP with five octapeptide repeats.‏ ‎‡9  1‏
919 ‎‡a  receptormediatedendocytosisandrecyclingofalphafetoproteininhumanblymphomaandtleukemiacells‏ ‎‡A  Receptor-mediated endocytosis and recycling of alpha-fetoprotein in human B-lymphoma and T-leukemia cells‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  SUDOC|066991714‏
996 ‎‡2  ISNI|000000005944845X‏
996 ‎‡2  LC|n 2002098544‏
996 ‎‡2  BNCHL|10000000000000000107077‏
996 ‎‡2  LC|n 85806499‏
996 ‎‡2  RERO|A025695163‏
996 ‎‡2  BNC|981058516704506706‏
996 ‎‡2  LC|no 94021363‏
996 ‎‡2  DNB|133006328‏
996 ‎‡2  LC|ns2014001748‏
996 ‎‡2  DNB|1053072554‏
996 ‎‡2  PLWABN|9814024545705606‏
996 ‎‡2  ISNI|0000000401713600‏
996 ‎‡2  ISNI|0000000073418484‏
996 ‎‡2  ISNI|0000000051551874‏
996 ‎‡2  BNE|XX897618‏
996 ‎‡2  LC|no2018068657‏
996 ‎‡2  ISNI|0000000121432986‏
996 ‎‡2  BNE|XX1040723‏
996 ‎‡2  J9U|987007426574505171‏
996 ‎‡2  ISNI|0000000084164010‏
996 ‎‡2  BNE|XX1030768‏
996 ‎‡2  ISNI|0000000060915828‏
996 ‎‡2  ISNI|0000000107712025‏
996 ‎‡2  ISNI|0000000060319110‏
996 ‎‡2  ISNI|0000000408271753‏
996 ‎‡2  ISNI|0000000080053591‏
996 ‎‡2  LC|ns2013003002‏
996 ‎‡2  BNE|XX5397033‏
996 ‎‡2  DNB|1064588662‏
996 ‎‡2  PLWABN|9810650798105606‏
996 ‎‡2  DNB|1057341819‏
996 ‎‡2  CAOONL|ncf11573586‏
996 ‎‡2  SUDOC|131073036‏
996 ‎‡2  BNC|981058612228306706‏
996 ‎‡2  RERO|A018540243‏
996 ‎‡2  BNCHL|10000000000000000069143‏
996 ‎‡2  SUDOC|111885531‏
996 ‎‡2  ISNI|0000000044938894‏
996 ‎‡2  LC|n 2003048397‏
996 ‎‡2  BNE|XX1658850‏
996 ‎‡2  BNCHL|10000000000000000134826‏
996 ‎‡2  SUDOC|118988409‏
996 ‎‡2  LC|ns2012005335‏
996 ‎‡2  NII|DA06427981‏
996 ‎‡2  LC|no 98078975‏
996 ‎‡2  BNF|13744562‏
996 ‎‡2  LC|ns2013000873‏
996 ‎‡2  SUDOC|152862412‏
996 ‎‡2  ISNI|0000000061090717‏
996 ‎‡2  PLWABN|9811724166705606‏
996 ‎‡2  ISNI|0000000087051070‏
996 ‎‡2  LC|nb2009027776‏
996 ‎‡2  DNB|1057344982‏
996 ‎‡2  LC|ns2011001949‏
996 ‎‡2  DNB|1056620447‏
996 ‎‡2  BAV|495_181817‏
996 ‎‡2  ISNI|000000005924836X‏
996 ‎‡2  BNCHL|10000000000000000866413‏
996 ‎‡2  RERO|A012071925‏
996 ‎‡2  LC|n 94015880‏
996 ‎‡2  LC|no2018091119‏
996 ‎‡2  SUDOC|120162199‏
996 ‎‡2  ISNI|0000000428291110‏
996 ‎‡2  BNE|XX1721051‏
996 ‎‡2  NTA|307981363‏
996 ‎‡2  DNB|1089781296‏
996 ‎‡2  LC|n 2010027205‏
996 ‎‡2  ISNI|0000000118442956‏
996 ‎‡2  LC|n 86869124‏
996 ‎‡2  BNE|XX6517693‏
996 ‎‡2  SUDOC|130897019‏
996 ‎‡2  LC|no2015134221‏
996 ‎‡2  BNE|XX1240974‏
996 ‎‡2  NTA|168669897‏
996 ‎‡2  LC|n 2016068176‏
996 ‎‡2  PTBNP|1496782‏
996 ‎‡2  SUDOC|170409872‏
996 ‎‡2  LC|n 93023682‏
996 ‎‡2  LC|ns2011001235‏
996 ‎‡2  DNB|1157280412‏
996 ‎‡2  BNC|981058514327206706‏
996 ‎‡2  BNE|XX825767‏
996 ‎‡2  BNE|XX5433310‏
996 ‎‡2  KRNLK|KAC2020Q0866‏
996 ‎‡2  ISNI|0000000072454029‏
996 ‎‡2  LC|ns2021002706‏
996 ‎‡2  BNC|981058530827106706‏
996 ‎‡2  BNCHL|10000000000000000830528‏
996 ‎‡2  BNCHL|10000000000000000820967‏
996 ‎‡2  LC|n 2014034285‏
996 ‎‡2  ISNI|0000000059294868‏
996 ‎‡2  LC|n 85087728‏
996 ‎‡2  ISNI|0000000059317185‏
996 ‎‡2  ISNI|0000000076716794‏
996 ‎‡2  BNE|XX835070‏
996 ‎‡2  BNE|XX1791011‏
996 ‎‡2  PLWABN|9810542392505606‏
996 ‎‡2  NSK|000611132‏
996 ‎‡2  RERO|A005714359‏
996 ‎‡2  BNE|XX1108412‏
996 ‎‡2  ISNI|000000005032424X‏
996 ‎‡2  LC|no2006069951‏
996 ‎‡2  LC|ns2021000372‏
996 ‎‡2  BNE|XX1166393‏
996 ‎‡2  BNE|XX5153416‏
996 ‎‡2  DNB|1208850466‏
996 ‎‡2  SUDOC|271067705‏
996 ‎‡2  DNB|1056788798‏
996 ‎‡2  LC|n 98084031‏
996 ‎‡2  ISNI|0000000409333178‏
996 ‎‡2  BNC|981061138659906706‏
996 ‎‡2  BNE|XX1720664‏
996 ‎‡2  DNB|1056246111‏
996 ‎‡2  ISNI|0000000072287099‏
996 ‎‡2  ISNI|0000000078075783‏
996 ‎‡2  SUDOC|258257202‏
996 ‎‡2  BNC|981060929701606706‏
996 ‎‡2  ISNI|0000000068294288‏
996 ‎‡2  DNB|143579258‏
996 ‎‡2  LC|no2010181573‏
996 ‎‡2  PTBNP|249502‏
996 ‎‡2  LC|no2022093042‏
996 ‎‡2  LC|n 85189640‏
996 ‎‡2  BNCHL|10000000000000000249936‏
996 ‎‡2  SUDOC|228918456‏
996 ‎‡2  ISNI|0000000395103784‏
996 ‎‡2  DNB|1166998630‏
996 ‎‡2  LC|nb2014026577‏
996 ‎‡2  BNE|XX5475370‏
996 ‎‡2  SUDOC|139255699‏
996 ‎‡2  ISNI|0000000118299643‏
996 ‎‡2  DNB|1274485371‏
996 ‎‡2  BNE|XX6271892‏
996 ‎‡2  CAOONL|ncf10529105‏
996 ‎‡2  BNE|XX4685865‏
996 ‎‡2  CAOONL|ncf11853547‏
996 ‎‡2  ISNI|0000000420369809‏
996 ‎‡2  BNE|XX6232150‏
996 ‎‡2  ISNI|0000000459660441‏
996 ‎‡2  KRNLK|KAC202279175‏
996 ‎‡2  LC|no2022137057‏
996 ‎‡2  NTA|132136198‏
996 ‎‡2  LC|no2003049915‏
996 ‎‡2  DNB|1056419466‏
996 ‎‡2  SUDOC|200713736‏
996 ‎‡2  J9U|987007448037005171‏
996 ‎‡2  DNB|1026519926‏
996 ‎‡2  ISNI|0000000514185349‏
996 ‎‡2  BNF|14550616‏
996 ‎‡2  LC|no2010008173‏
996 ‎‡2  BNE|XX4690788‏
996 ‎‡2  BNE|XX1080481‏
996 ‎‡2  ISNI|0000000060157764‏
996 ‎‡2  ISNI|0000000048673731‏
996 ‎‡2  BIBSYS|8041876‏
996 ‎‡2  LC|nb2011005508‏
996 ‎‡2  PTBNP|1531928‏
996 ‎‡2  BNCHL|10000000000000000124669‏
996 ‎‡2  RERO|A021694085‏
996 ‎‡2  ISNI|000000007498594X‏
996 ‎‡2  LC|no2009098187‏
996 ‎‡2  DNB|135613523‏
996 ‎‡2  LC|no2010061177‏
996 ‎‡2  BNC|981058511634806706‏
996 ‎‡2  BNF|12281436‏
996 ‎‡2  DNB|1212531035‏
996 ‎‡2  SUDOC|085981508‏
996 ‎‡2  PLWABN|9810582276305606‏
996 ‎‡2  SELIBR|328979‏
996 ‎‡2  DNB|1201381924‏
996 ‎‡2  BNE|XX4691547‏
996 ‎‡2  LC|nr2004026254‏
996 ‎‡2  LC|no2024000176‏
996 ‎‡2  BNC|981058514448906706‏
996 ‎‡2  PTBNP|195445‏
996 ‎‡2  PLWABN|9810700905405606‏
996 ‎‡2  NUKAT|n 2016052708‏
996 ‎‡2  LC|no2007040002‏
996 ‎‡2  BNE|XX1310925‏
996 ‎‡2  ISNI|0000000036357088‏
996 ‎‡2  BNE|XX1223023‏
996 ‎‡2  BNCHL|10000000000000000039975‏
996 ‎‡2  NII|DA17664118‏
996 ‎‡2  SUDOC|15021698X‏
996 ‎‡2  CAOONL|ncf11351960‏
996 ‎‡2  RERO|A000028843‏
996 ‎‡2  LC|nb 98033388‏
996 ‎‡2  LC|no2008169128‏
996 ‎‡2  LC|n 92087220‏
996 ‎‡2  BNF|16242355‏
996 ‎‡2  J9U|987007353480105171‏
996 ‎‡2  ISNI|0000000079300428‏
996 ‎‡2  LC|no2008089571‏
996 ‎‡2  ISNI|0000000428333616‏
996 ‎‡2  LC|n 2009071691‏
996 ‎‡2  LC|no2013124256‏
996 ‎‡2  LC|no2003000761‏
996 ‎‡2  LC|no 92004551‏
996 ‎‡2  NII|DB00043532‏
996 ‎‡2  BNF|13975954‏
996 ‎‡2  BLBNB|000283045‏
996 ‎‡2  LC|n 2019026215‏
996 ‎‡2  DNB|118198629X‏
996 ‎‡2  LC|no2008089714‏
996 ‎‡2  BNE|XX1697083‏
996 ‎‡2  ISNI|0000000079738569‏
996 ‎‡2  SUDOC|185212816‏
996 ‎‡2  LC|n 2023053679‏
996 ‎‡2  B2Q|0000353498‏
996 ‎‡2  RERO|A000062364‏
996 ‎‡2  SUDOC|251355861‏
996 ‎‡2  ISNI|0000000107799706‏
996 ‎‡2  BIBSYS|90525591‏
996 ‎‡2  SUDOC|155843699‏
996 ‎‡2  ISNI|0000000083683476‏
996 ‎‡2  CAOONL|ncf11614443‏
996 ‎‡2  LC|no2013120378‏
996 ‎‡2  LC|no2010156715‏
996 ‎‡2  ISNI|0000000436063142‏
996 ‎‡2  BNE|XX921426‏
996 ‎‡2  LC|no2008093773‏
996 ‎‡2  BNE|XX1104641‏
996 ‎‡2  LC|ns2011001146‏
996 ‎‡2  SUDOC|156874784‏
996 ‎‡2  BNE|XX1507061‏
996 ‎‡2  LC|no 95042895‏
996 ‎‡2  SUDOC|084720921‏
996 ‎‡2  LC|no2022025479‏
996 ‎‡2  DNB|1012623432‏
996 ‎‡2  LC|ns2019000542‏
996 ‎‡2  LC|no2006015639‏
996 ‎‡2  LC|no2009039604‏
996 ‎‡2  BNCHL|10000000000000000137135‏
996 ‎‡2  RERO|A003433500‏
996 ‎‡2  RERO|A010159348‏
996 ‎‡2  PTBNP|1766106‏
996 ‎‡2  LC|no2011118511‏
996 ‎‡2  LC|no2019152818‏
996 ‎‡2  BNF|15997296‏
996 ‎‡2  ARBABN|000025686‏
996 ‎‡2  ISNI|0000000051458688‏
996 ‎‡2  BNE|XX1223060‏
996 ‎‡2  LC|n 2014074482‏
996 ‎‡2  BNC|981058518627506706‏
996 ‎‡2  LC|ns2021003235‏
996 ‎‡2  ISNI|0000000043063846‏
996 ‎‡2  LC|no2010175464‏
996 ‎‡2  NUKAT|n 2009113926‏
996 ‎‡2  BNE|XX4814967‏
997 ‎‡a  1960 0 lived 0000 0‏ ‎‡9  1‏
998 ‎‡a  Fabara Torres, Juan Carlos,‏ ‎‡2  SUDOC|174220839‏ ‎‡3  suggested‏